Figure 1From: The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis Effects of ATO and nilotinib on cell proliferation. Cells were treated with 1 μM ATO and 5 nM nilotinib alone or in combination for 24, 48 or 72 h, respectively. Cell proliferation was determined using a MTT assay. CML-BC cells were derived from five patients with CML-BC and data were calculated from five independent experiments. **P < 0.01 vs. control.Back to article page